X

Trial Profile

Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer (JCOG1106)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Aug 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
Indications Adenocarcinoma; Adenosquamous carcinoma; Pancreatic cancer; Squamous cell cancer
Focus Therapeutic Use

Most Recent Events

31 Jul 2023 Results of exploratory subgroup analysis assessoing the Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer published in the Japanese Journal of Clinical Oncology
31 Aug 2022 Status changed from active, no longer recruiting to completed.
08 Feb 2021 Results published in the Japanese Journal of Clinical Oncology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com